Pubblicazioni ufficiali Theranexus

Azioni

Tempo reale Euronext Paris Altri mercati azionari 17:18:02 30/04/2024			Variaz. 5gg	Var. 1 gen.
1,15 ^EUR	-0,43%		+10,05%	+2,68%

2023	Theranexus Société Anonyme riporta i risultati degli utili per il semestre conclusosi il 30 giugno 2023	CI
2023	Theranexus e BBDF ottengono l'approvazione della FDA sugli endpoint di efficacia della sperimentazione di Fase III per la valutazione di Batten-1 nella malattia di Batten CLN3	CI

1st quarter turnover	29/04	CO
Annual results	29/04	CO
Annual results	29/04	CO
Annual results	29/04	CO
Annual results	29/04	CO
Monthly statement on voting rights	31/03	CO
Changes in management and corporate officers	11/03	CO
Changes in management and corporate officers	11/03	CO
4th quarter turnover	14/02	CO
4th quarter turnover	14/02	CO
3rd quarter turnover	17/10/23	CO
3rd quarter turnover	17/10/23	CO
1st-half-year results	28/09/23	CO
1st-half-year results	28/09/23	CO
Monthly statement on voting rights	30/08/23	CO
Monthly statement on voting rights	31/07/23	CO
Shareholders meeting voting results	08/06/23	CO
Mixed general Shareholders meeting notice	24/05/23	CO
Mixed general Shareholders meeting notice	03/05/23	CO
Universal registration document	26/04/23	CO
Management Report	12/04/23	CO
Auditors Report	12/04/23	CO
1st quarter turnover	12/04/23	CO
1st quarter turnover	12/04/23	CO
Annual results	12/04/23	CO